DOD and HHS awarded $20 million contract to On Demand Pharmaceuticals to develop critical pharmaceutical ingredients
On Sept. 28, 2020, the U.S. Departments of Defense and Health and Human Services signed a $20 million contract award with On Demand Pharmaceuticals (ODP) to develop a domestic production capability for critical active pharmaceutical ingredients (APIs) and final formulated medicines using their proprietary Pharmacy on Demand technology.
Tags:
Source: U.S. Department of Defense
Credit:
